Moonlight Bio
Moonlight Bio is a biotech company in United States. It has 1 recorded funding round, most recently a Seed in 2023 (est.).
- Business Model
- B2B
- Website
- moonlightbio.us
- Last Round
- SeedJan 2023
- Rounds
- 1
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Moonlight Bio is a biotech company developing T cell therapies for cancer patients by harnessing evolutionary forces to achieve unparalleled advances in T cell potency. The company is collaborating with partners such as Biocytogen to advance its cell therapy pipeline using libraries of antibody binders, aiming for unrivaled clinical outcomes in cancer treatment.
Summary
Its most recent funding was a Seed round in 2023 (est.). Investors include ARCH Venture Partners, Venrock and Parker Institute for Cancer Immunotherapy.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
2023 (est.)
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/moonlight-bio"><img src="https://indexed.vc/api/badge/company/moonlight-bio" alt="Moonlight Bio on Indexed.vc" width="260" height="76" /></a>